Breastfeeding vs. Formula: Impact on Allergies?

Article

Breastfeeding has been linked to various benefits, including lower odds of childhood leukemia and reduced multiple sclerosis relapse risk in mothers. Unfortunately, reducing the risk of the baby developing allergies does not make the list.

Breastfeeding has been linked to various benefits, including lower odds of childhood leukemia and reduced multiple sclerosis relapse risk in mothers. Unfortunately, reducing the risk of the baby developing allergies does not make the list.

It’s been thought that breastfeeding can reduce asthma, eczema, food allergies, and allergic rhinitis (hay fever) in children, but this does not appear to be true, according to a study that will be presented at the 2015 American College of Allergy, Asthma, and Immunology Annual Scientific Meeting (ACAAI 2015) in San Antonio, Texas.

Lead author Quindelyn Cook, MD, and colleagues evaluated 194 patients ranging in age from 4 to 18. All of the participants had been diagnosed with hay fever by a skin prick test. It was noted which children were breastfed and which ones were not. The results became pretty clear once the authors compared the 134 breastfed children and the 60 formula fed children.

“We found both groups had similar numbers of kids with hay fever. We also found both groups had similar numbers of kids with asthma, eczema and food allergy,” Cook, a pediatrician in Chicago, detailed in a news release.

Therefore, it does not appear that breastfeeding has a significant influence on a child’s allergies.

“We know breastfeeding is good for babies, and new mothers should continue to breastfeed,” said one of the authors Christina Ciaccio, MD. “Larger studies need to be done to determine how these results might apply to the larger population.”

Recent Videos
Arshad Khanani, MD: Four-Year Outcomes of Faricimab for DME in RHONE-X | Image Credit: Sierra Eye Associates
Dilraj Grewal, MD: Development of MNV in Eyes with Geographic Atrophy in GATHER | Image Credit: Duke Eye Center
Margaret Chang, MD: Two-Year Outcomes of the PDS for Diabetic Retinopathy | Image Credit: Retina Consultants Medical Group
Carl C. Awh, MD: | Image Credit:
Raj K. Maturi, MD: 4D-150 for nAMD in PRISM Population Extension Cohort | Image Credit: Retina Partners Midwest
Charles C. Wykoff, MD, PhD: Interim Analysis on Ixo-Vec Gene Therapy for nAMD | Image Credit: Retina Consultants of Texas
Sunir J. Garg, MD: Pegcetacoplan Preserves Visual Function on Microperimetry | Image Credit: Wills Eye Hospital
Edward H. Wood, MD: Pharmacodynamics of Subretinal RGX-314 for Wet AMD | Image Credit: Austin Retina Associates
Dilsher Dhoot, MD: OTX-TKI for NPDR in Interim Phase 1 HELIOS Results  | Image Credit: LinkedIn
Katherine Talcott, MD: Baseline EZ Integrity Features Predict GA Progression | Image Credit: LinkedIn
© 2024 MJH Life Sciences

All rights reserved.